Nureca Limited (NSE:NURECA)
239.69
-12.74 (-5.05%)
Sep 22, 2025, 3:30 PM IST
Nureca Revenue
Nureca had revenue of 341.76M INR in the quarter ending June 30, 2025, with 68.61% growth. This brings the company's revenue in the last twelve months to 1.24B, up 35.84% year-over-year. In the fiscal year ending March 31, 2025, Nureca had annual revenue of 1.10B with 19.29% growth.
Revenue (ttm)
1.24B
Revenue Growth
+35.84%
P/S Ratio
1.94
Revenue / Employee
7.23M
Employees
171
Market Cap
2.40B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 1.10B | 177.33M | 19.29% |
Mar 31, 2024 | 919.28M | -193.95M | -17.42% |
Mar 31, 2023 | 1.11B | -1.44B | -56.44% |
Mar 31, 2022 | 2.56B | 420.94M | 19.72% |
Mar 31, 2021 | 2.13B | 1.14B | 114.69% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Divi's Laboratories | 96.52B |
Cipla | 274.80B |
Apollo Hospitals Enterprise | 225.51B |
Mankind Pharma | 129.10B |
Zydus Lifesciences | 236.08B |
Fortis Healthcare | 80.94B |
Alkem Laboratories | 133.04B |
Nureca News
- 5 months ago - Nureca shares jump over 3% as Dr Trust & Dr Physio gear up to launch on Swiggy Instamart - Business Upturn
- 1 year ago - Nureca shares surge 6% after company signs distribution agreement - Business Upturn